What is Lipocine Inc (LPCN) stock price today?

Lipocine Inc (LPCN) currently trades at $2.33 per share. The stock has a market capitalization of $19.02M and a P/E ratio of —x.

Is LPCN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Lipocine Inc has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Lipocine Inc's revenue and earnings?

Lipocine Inc has trailing twelve-month (TTM) revenue of $1.98M with profit margins of 0.00%. Earnings per share (EPS) is $-1.77.

LPCN

Lipocine Inc

NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY

$2.33

+0.00% today

Updated 2026-05-01

Market cap

$19.02M

P/E ratio

—

P/S ratio

9.62x

EPS (TTM)

$-1.77

Dividend yield

—

52W range

$2 – $12

Volume

0.5M

Market cap

$19.02M

P/E ratio

—

P/S ratio

9.62x

EPS (TTM)

$-1.77

Dividend yield

—

52W range

$2 – $12

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$6.00

+157.51%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.92M

- Revenue declining -67.20% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$500000.00	$-2.85M	$11.20M	$1.98M	$1.98M
Net income	$-10.76M	$-16.35M	$8352.00	$-9.63M	$-2.37M
EPS	—	—	—	—	$-1.77
Free cash flow	$-12.10M	$-11.88M	$-1.31M	$-9.76M	$-2.92M
Profit margin	-2,151.73%	573.59%	0.07%	-487.06%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LPCN	$19.02M	22	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Lipocine Inc trades at $2.33. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $1.98M.

Frequently asked questions

What is Lipocine Inc's stock price?

Lipocine Inc (LPCN) trades at $2.33.

Is Lipocine Inc overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Lipocine Inc (LPCN)?

The analyst target price is $6.00, representing +157.5% upside from the current price of $2.33.

What is Lipocine Inc's revenue?

TTM revenue is $1.98M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio9.62x

ROE-54.30%

Beta1.09

50D MA$6.29

200D MA$4.84

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LPCN vs LLY →LPCN vs JNJ →LPCN vs ABBV →Stock screener →